Meta-Analysis in Healthcare: Advancing Evidence-Based Practice for Healthcare Professionals

---

LIVEDHPAMA

Saturday, September 27, 2025, 7:30 AM - Sunday, September 28, 2025, 4:00 PM, Hilton Hotel Doha, Doha, Qatar

This 2-day CPD course provides hands-on training in conducting and interpreting meta-analyses for clinical and research applications. Participants will learn statistical methodologies, software tools (STATA & R), and best practices for synthesizing healthcare evidence. Through interactive lectures and practical sessions, attendees will gain proficiency in effect size estimation, heterogeneity assessment, subgroup analysis, sensitivity analysis, meta-regression, and result visualization. Designed for physicians, nurses, pharmacists, and researchers, this course addresses key knowledge gaps in meta-analysis methodology, empowering professionals to apply evidence-based insights to their practice.

September 27, 2025

Start time: 7:30 AM

End time: 4:00 PM

September 28, 2025

Start time: 7:30 AM

End time: 4:00 PM

1. Use R and STATA to conduct meta-analyses.
2. Evaluate heterogeneity and quality of evidence (using GRADE) to ensure methodological rigor.
3. Translate meta-analysis findings into clinical and research practice.

Early bird rate until August 27, 2025 - USD 98 ; QAR 358

Regular fees starting August 28, 2025 - USD 130 ; QAR 475

Changes or Cancellations

• Name changes or substitutions are not permitted.

• All cancellation and refund requests must be made in writing and submitted via email to [email protected].

• For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.

• We will attempt to process the refund within 30 days of receiving any cancellation request.

• Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 13.0 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this workshop for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Course Director and Speaker

Dr. Alaa Ali Abd-Alrazaq has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Course Speakers

Dr. Sonia Chaabane has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Dr. Jennifer Hirst has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Dr. Jose Ordonez-Mena has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Scientific Planning Committee

Mr. Ahmad Mohammad Dardoor has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Mr. Ahmad R. Al-Qudimat has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Dr. Hashem Abu Serhan has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Dr. Mais Abu Ghosh has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Mr. Ahmad Makhlouf has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

Course Coordinator

Ms. Nour El Messiri has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and will not be discussing unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.